A multiple technology-based and individually-tailored Sit Less program for people with cardiovascular disease: A randomized controlled trial study protocol.
Sedentary behavior, a key modifiable risk factor for cardiovascular disease, is prevalent among cardiovascular disease patients. However, few interventions target sedentary behavior in this group. This paper describes the protocol of a parallel two-group randomized controlled trial for a novel multi...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0302582&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841560392121188352 |
|---|---|
| author | Chorong Park Britta Larsen Mulubrhan Mogos James Muchira Mary Dietrich Marianna LaNoue Jason Jean John Norfleet Abigail Doyle Soojung Ahn Shelagh Mulvaney |
| author_facet | Chorong Park Britta Larsen Mulubrhan Mogos James Muchira Mary Dietrich Marianna LaNoue Jason Jean John Norfleet Abigail Doyle Soojung Ahn Shelagh Mulvaney |
| author_sort | Chorong Park |
| collection | DOAJ |
| description | Sedentary behavior, a key modifiable risk factor for cardiovascular disease, is prevalent among cardiovascular disease patients. However, few interventions target sedentary behavior in this group. This paper describes the protocol of a parallel two-group randomized controlled trial for a novel multi-technology sedentary behavior reduction intervention for cardiovascular disease patients (registered at Clinicaltrial.gov, NCT05534256). The pilot trial (n = 70) will test a 12-week "Sit Less" program, based on Habit Formation theory. The 35 participants in the intervention group will receive an instructional goal-setting session, a Fitbit for movement prompts, a smart water bottle (HidrateSpark) to promote hydration and encourage restroom breaks, and weekly personalized text messages. A control group of 35 will receive the American Heart Association's "Answers by Heart" fact sheets. This trial will assess the feasibility and acceptability of implementing the "Sit Less" program with cardiovascular disease patients and the program's primary efficacy in changing sedentary behavior, measured by the activPAL activity tracker. Secondary outcomes include physical activity levels, cardiometabolic biomarkers, and patient-centered outcomes (i.e. sedentary behavior self-efficacy, habit strength, and fear of movement). This study leverages commonly used mobile and wearable technologies to address sedentary behavior in cardiovascular disease patients, a high-risk group. Its findings on the feasibility, acceptability and primary efficacy of the intervention hold promise for broad dissemination. |
| format | Article |
| id | doaj-art-235b2aa4f07a48679782e2579ea08e86 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-235b2aa4f07a48679782e2579ea08e862025-01-04T05:31:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01195e030258210.1371/journal.pone.0302582A multiple technology-based and individually-tailored Sit Less program for people with cardiovascular disease: A randomized controlled trial study protocol.Chorong ParkBritta LarsenMulubrhan MogosJames MuchiraMary DietrichMarianna LaNoueJason JeanJohn NorfleetAbigail DoyleSoojung AhnShelagh MulvaneySedentary behavior, a key modifiable risk factor for cardiovascular disease, is prevalent among cardiovascular disease patients. However, few interventions target sedentary behavior in this group. This paper describes the protocol of a parallel two-group randomized controlled trial for a novel multi-technology sedentary behavior reduction intervention for cardiovascular disease patients (registered at Clinicaltrial.gov, NCT05534256). The pilot trial (n = 70) will test a 12-week "Sit Less" program, based on Habit Formation theory. The 35 participants in the intervention group will receive an instructional goal-setting session, a Fitbit for movement prompts, a smart water bottle (HidrateSpark) to promote hydration and encourage restroom breaks, and weekly personalized text messages. A control group of 35 will receive the American Heart Association's "Answers by Heart" fact sheets. This trial will assess the feasibility and acceptability of implementing the "Sit Less" program with cardiovascular disease patients and the program's primary efficacy in changing sedentary behavior, measured by the activPAL activity tracker. Secondary outcomes include physical activity levels, cardiometabolic biomarkers, and patient-centered outcomes (i.e. sedentary behavior self-efficacy, habit strength, and fear of movement). This study leverages commonly used mobile and wearable technologies to address sedentary behavior in cardiovascular disease patients, a high-risk group. Its findings on the feasibility, acceptability and primary efficacy of the intervention hold promise for broad dissemination.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0302582&type=printable |
| spellingShingle | Chorong Park Britta Larsen Mulubrhan Mogos James Muchira Mary Dietrich Marianna LaNoue Jason Jean John Norfleet Abigail Doyle Soojung Ahn Shelagh Mulvaney A multiple technology-based and individually-tailored Sit Less program for people with cardiovascular disease: A randomized controlled trial study protocol. PLoS ONE |
| title | A multiple technology-based and individually-tailored Sit Less program for people with cardiovascular disease: A randomized controlled trial study protocol. |
| title_full | A multiple technology-based and individually-tailored Sit Less program for people with cardiovascular disease: A randomized controlled trial study protocol. |
| title_fullStr | A multiple technology-based and individually-tailored Sit Less program for people with cardiovascular disease: A randomized controlled trial study protocol. |
| title_full_unstemmed | A multiple technology-based and individually-tailored Sit Less program for people with cardiovascular disease: A randomized controlled trial study protocol. |
| title_short | A multiple technology-based and individually-tailored Sit Less program for people with cardiovascular disease: A randomized controlled trial study protocol. |
| title_sort | multiple technology based and individually tailored sit less program for people with cardiovascular disease a randomized controlled trial study protocol |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0302582&type=printable |
| work_keys_str_mv | AT chorongpark amultipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT brittalarsen amultipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT mulubrhanmogos amultipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT jamesmuchira amultipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT marydietrich amultipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT mariannalanoue amultipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT jasonjean amultipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT johnnorfleet amultipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT abigaildoyle amultipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT soojungahn amultipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT shelaghmulvaney amultipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT chorongpark multipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT brittalarsen multipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT mulubrhanmogos multipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT jamesmuchira multipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT marydietrich multipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT mariannalanoue multipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT jasonjean multipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT johnnorfleet multipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT abigaildoyle multipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT soojungahn multipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol AT shelaghmulvaney multipletechnologybasedandindividuallytailoredsitlessprogramforpeoplewithcardiovasculardiseasearandomizedcontrolledtrialstudyprotocol |